Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $267,730.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 20,500 shares of Alignment Healthcare stock in a transaction on Monday, November 4th. The shares were sold at an average price of $13.06, for a total transaction of $267,730.00. Following the completion of the sale, the insider now directly owns 355,444 shares of the company’s stock, valued at approximately $4,642,098.64. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Hakan Kardes also recently made the following trade(s):

• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.98, for a total value of $58,410.00.
• On Thursday, September 12th, Hakan Kardes sold 25,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.48, for a total transaction of $287,000.00.

Alignment Healthcare Trading Down 0.1 %

Shares of ALHC opened at $13.28 on Wednesday. The business’s 50-day moving average price is $10.89 and its 200-day moving average price is $8.90. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $13.45. The stock has a market cap of $2.55 billion, a PE ratio of -17.25 and a beta of 1.45.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). The business had revenue of $692.43 million for the quarter, compared to analysts’ expectations of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business’s revenue for the quarter was up 51.6% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.19) EPS. On average, equities analysts forecast that Alignment Healthcare, Inc. will post -0.68 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ALHC has been the subject of several recent research reports. UBS Group upped their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a report on Wednesday, October 30th. Piper Sandler reiterated an “overweight” rating and set a $10.00 target price (up from $8.00) on shares of Alignment Healthcare in a research note on Tuesday, August 6th. Barclays increased their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. TD Cowen boosted their target price on shares of Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. Finally, Stifel Nicolaus raised their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a research note on Friday, July 26th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $10.33.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors have recently added to or reduced their stakes in ALHC. Deerfield Management Company L.P. Series C grew its holdings in shares of Alignment Healthcare by 31.8% during the second quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after purchasing an additional 2,630,788 shares in the last quarter. Vanguard Group Inc. grew its stake in Alignment Healthcare by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock worth $45,828,000 after buying an additional 93,262 shares in the last quarter. Hood River Capital Management LLC increased its holdings in shares of Alignment Healthcare by 6.4% in the 2nd quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company’s stock worth $24,294,000 after buying an additional 185,854 shares during the last quarter. William Blair Investment Management LLC lifted its holdings in shares of Alignment Healthcare by 94.4% during the 2nd quarter. William Blair Investment Management LLC now owns 3,104,681 shares of the company’s stock worth $24,279,000 after acquiring an additional 1,507,759 shares during the last quarter. Finally, Renaissance Technologies LLC grew its position in Alignment Healthcare by 16.8% in the second quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company’s stock worth $12,245,000 after acquiring an additional 225,000 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.